IRCCS Gruppo Multimedica

Sesto San Giovanni (MI) 20099

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure

Studies at this site

• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed